Sterling Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $45.4K | Buy |
|
|||||
|
2025
Q2 | $12.7K | Buy |
|
|||||
|
2025
Q1 | $13.7K | Sell |
|
|||||
|
2024
Q4 | $39.3K | Buy |
|
|||||
|
2024
Q3 | $8.44K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $262K | Sell |
|
|||||
|
2017
Q2 | $47.8M | Sell |
|
|||||
|
2017
Q1 | $36.1M | Sell |
|
|||||
|
2016
Q4 | $31.4M | Sell |
|
|||||
|
2016
Q3 | $43M | Buy |
|
|||||
|
2016
Q2 | $46.6M | Buy |
|
|||||
|
2016
Q1 | $53.6M | Sell |
|
|||||
|
2015
Q4 | $66.6M | Sell |
|
|||||
|
2015
Q3 | $69.2M | Sell |
|
|||||
|
2015
Q2 | $66.5M | Buy |
|
|||||
|
2015
Q1 | $59.4M | Sell |
|
|||||
|
2014
Q4 | $61.1M | Buy |
|
|||||
|
2014
Q3 | $27.9M | Sell |
|
|||||
|
2014
Q2 | $70.4M | Sell |
|
|||||
|
2014
Q1 | $73.2M | Sell |
|
|||||
|
2013
Q4 | $55M | Buy |
|
|||||
|
2013
Q3 | $56.1M | Buy |
|
|||||
|
2013
Q2 | $56.8M | Buy |
|